G. Simonneau

6.6k citations

34 papers · 1.7k indexed · 1 hit paper · h-index 15

Impact in

Pulmonary and Respiratory Medicine top 1%
- Pulmonary Hypertension Research and Treatments
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Chronic Obstructive Pulmonary Disease (COPD) Research
Cardiology and Cardiovascular Medicine top 2%
- Cardiovascular Issues in Pregnancy
- Cardiovascular Function and Risk Factors
- Heart Failure Treatment and Management

Papers in

Internal Medicine 4
- Venous Thromboembolism Diagnosis and Management 4
Pulmonary and Respiratory Medicine 30
- Pulmonary Hypertension Research and Treatments 26
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 4
- Respiratory Support and Mechanisms 3

Co-authors: Marc Humbert Olivier Sitbon Jérôme Le Pavec Xavier Jaïs Vincent Cottin Hervé Mal Grégoire Prévôt David Montani
Journals: European Respiratory Journal (5 papers)Thrombosis Research (3 papers)Thorax (2 papers)Annals of Internal Medicine (1 paper)Annals of the Rheumatic Diseases (1 paper)
Partner nations: France United States Canada

In The Last Decade

G. Simonneau

31 papers receiving 1.6k citations

Hit Papers

align trajectories log scale

Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension 2010 · 470 citations

Peers

Countries citing papers authored by G. Simonneau

Since Specialization

Citations

This map shows the geographic impact of G. Simonneau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Simonneau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Simonneau more than expected).

Fields of papers citing papers by G. Simonneau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Simonneau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Simonneau. The network helps show where G. Simonneau may publish in the future.

Co-authorship network

The 25 scholars most cited alongside G. Simonneau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with G. Simonneau Line = papers co-authored together G. Simonneau links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Sustained effect of macitentan, a novel oral endothelin receptor antagonist, on exercise capacity and the association of its measure with long-term outcomes in pulmonary arterial hypertension European Heart Journal ·Nazzareno Galiè, Richard N. Channick, Marion Delcroix, Hossein Ardeschir Ghofrani, Pavel Jansa, V.T. Nochevny, G. Simonneau, Lewis J. Rubin	2013	3
2	Diagnostic et prise en charge de l’hypertension pulmonaire en 2009. Commentaires sur les nouvelles recommandations de l’European Society of Cardiology (ESC) et de l’European Respiratory Society (ERS) Revue des Maladies Respiratoires ·Olivier Sanchez, Marc Humbert, Olivier Sitbon, Xavier Jaïs, G. Simonneau	2010	7
3	Targeting of c-kit+ haematopoietic progenitor cells prevents hypoxic pulmonary hypertension European Respiratory Journal ·Natalia Gambaryan, Frédéric Perros, David Montani, Sylvia Cohen‐Kaminsky, Michel Mazmanian, J. F. Renaud, G. Simonneau, Alain Lombet, Marc Humbert	2010	69
4	Current management approaches to portopulmonary hypertension International Journal of Clinical Practice ·Krzysztof T. Koniecki, Dermot S. O’Callaghan, Xiaoqun Tan, Jérôme Le Pavec, P. Hervé, Xavier Jaïs, Andrei Seferian, Marc Humbert, G. Simonneau, Olivier Sitbon	2010	15
5	Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension European Respiratory Journal ·Marc Humbert, Olivier Sitbon, A. Yaïci, David Montani, Dermot S. O’Callaghan, Xavier Jaïs, Florence Parent, Laurent Savale, Delphine Natali, Sven Günther, Ari Chaouat, F. Chabot, J.F. Cordier, Gilbert Habib, Virginie Gressin, Zhi‐Cheng Jing, Rogério Souza, G. Simonneau Hit paper breakdown →	2010	470
6	Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: A randomized trial (Annals of Internal Medicine (2008) 149, (521-530)) Annals of Internal Medicine ·G. Simonneau, Leona J. Rubin, Nazzareno Galiè, Robyn J. Barst, Thomas R. Fleming, Adaani Frost	2009	106
7	Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome European Respiratory Journal ·Vincent Cottin, Jérôme Le Pavec, Grégoire Prévôt, Hervé Mal, Marc Humbert, G. Simonneau, Kamalpreet China, (unknown)	2009	282
8	Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil Lara D. Veeken ·David Launay, Olivier Sitbon, Jérôme Le Pavec, Laurent Savale, Colas Tchérakian, A. Yaïci, L. Achouh, Florence Parent, Xavier Jaïs, G. Simonneau, Marc Humbert	2009	70
9	Antifibroblast antibodies from systemic sclerosis patients bind to α-enolase and are associated with interstitial lung disease Annals of the Rheumatic Diseases ·Benjamin Terrier, M.C. Tamby, Luc Camoin, Philippe Guilpain, A. Bérezné, Nicolas Tamas, Cédric Broussard, J Merickova, Marc Humbert, G. Simonneau, L Guillevin, Luc Mouthon	2009	51
10	Diagnostic et prise en charge de l’hypertension pulmonaire postembolique : le rôle du pneumologue Revue de Pneumologie Clinique ·I. Frachon, Xavier Jaïs, Christophe Leroyer, Yannick Jobic, Seojin Ku, G. Simonneau, P Dartevelle	2008	2
11	Adénopathies hilaires compressives sur les artères pulmonaires au cours d’une sarcoïdose Revue des Maladies Respiratoires ·寧人辻, Sophie Maître, A. Resten, Valérie Lacroix, Marc Humbert, G. Simonneau, D. Musset	2007	2
12	Antibodies to fibroblasts in idiopathic and scleroderma-associated pulmonary hypertension European Respiratory Journal ·M.C. Tamby, Marc Humbert, Philippe Guilpain, Amélie Servettaz, N. Dupin, James E. Christner, G. Simonneau, Jean‐David Fermanian, Bernard Weill, L Guillevin, Luc Mouthon	2006	103
13	Heart rate responses during the 6-minute walk test in pulmonary arterial hypertension European Respiratory Journal ·Steeve Provencher, D. S. Chemla, P. Hervé, Olivier Sitbon, Marc Humbert, G. Simonneau	2005	84
14	Le traitement antithrombotique de la maladie thromboembolique veineuse Revue des Maladies Respiratoires ·A. Achkar, MH Horellou, Florence Parent, Ismaı̈l Elalamy, J. Conard, Howard C. Cross, G. Simonneau	2005	0
15	Severe pulmonary arterial hypertension in type 1 glycogen storage disease European Journal of Pediatrics ·Marc Humbert, Philippe Labrune, G. Simonneau	2002	18
16	Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary hypertension: a placebo-controlled study The Journal of Heart and Lung Transplantation ·Richard N. Channick, David B. Badesch, Victor F. Tapson, G. Simonneau, Antoine Congar, Adaani Frost, Sébastiên Roux, Maurizio Rainisio, F. Bodin, Leona J. Rubin	2001	78
17	Treatment of pulmonary hypertension secondary to connective tissue diseases Thorax ·Olivier Sanchez, Marc Humbert, Olivier Sitbon, G. Simonneau	1999	82
18	Urinary cGMP concentrations in severe primary pulmonary hypertension Thorax ·أحمد الکحکی, Marc Humbert, J Francoual, Catherine Claise, P Duroux, G. Simonneau, A Lindenbaum	1998	40
19	Appetite-suppressant drugs and the risk of primary pulmonary hypertension Pneumologie ·Lucien Abenhaim, Yola Moride, F Brénot, Stuart Rich, W. van Zanten, Xavier Kurz, T W Higenbottam, Caroline Oakley, E.F.M. Wouters, Michel Aubier, G. Simonneau, Bernard Bégaud	1997	7
20	Frequency of mechanical ventilation and respiratory activity after double lung transplantation Respiration Physiology ·Frédéric Lofaso, G. Simonneau, François Le Roy Ladurie, Jacques Cerrina, Alain Chapelier, F Brénot, P Dartevelle, Philippe Hervé	1993	12

About G. Simonneau

G. Simonneau is a scholar working on Internal Medicine, Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine, Hepatology and Emergency Medicine, having authored 34 papers that have together received 1.7k indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (26 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers), Cardiovascular Function and Risk Factors (4 papers), Systemic Sclerosis and Related Diseases (4 papers), Venous Thromboembolism Diagnosis and Management (4 papers), Cardiovascular Issues in Pregnancy (4 papers), Heparin-Induced Thrombocytopenia and Thrombosis (3 papers) and Respiratory Support and Mechanisms (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.5k citations), Cardiology and Cardiovascular Medicine (742 citations), Genetics (294 citations), Hepatology (136 citations) and Pathology and Forensic Medicine (213 citations). G. Simonneau has collaborated with scholars based in France, United States and Canada. Frequent co-authors include Marc Humbert, Olivier Sitbon, Jérôme Le Pavec, Xavier Jaïs, Vincent Cottin, Hervé Mal, Grégoire Prévôt, David Montani, Laurent Savale and Florence Parent. Their work appears in journals such as European Respiratory Journal, Thrombosis Research, Thorax, Annals of Internal Medicine and Annals of the Rheumatic Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact